Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06473532 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure

Study acronym: TEXT4HF
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 26 participants (planned 30) · Primary completion date changed from estimate of Dec 30, 2025 to Feb 10, 2026 · Eligibility criteria expanded, about 13 words · 3 more Show 6 more changesShow less
    • Final enrollment: 26 participants (planned 30)
    • Primary completion date changed from estimate of Dec 30, 2025 to Feb 10, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 5 of 8 entries
    • Study description revised
    • Site details revised
  2. Secondary endpoints revised (8) Eligibility criteria expanded, about 3 words · Study description shortened, about 3 wordsv10 Show 2 more changesShow less
    • Eligibility criteria expanded, about 3 words
    • Study description shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: Mar 30, 2025 to Dec 30, 2025 Completion date: Jun 30, 2025 to Jun 30, 2026 · Site contact updated · Eligibility criteria expanded, about 3 wordsv9 Show 3 more changesShow less
    • Completion date: Jun 30, 2025 to Jun 30, 2026
    • Site contact updated
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  4. Site contact updated Study description expanded, about 1 wordv8 Show 1 more changeShow less
    • Study description expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  5. Eligibility criteria expanded, about 6 wordsv7 See this version in full on ClinicalTrials.gov ↗
Show 5 earlier versionsHide 5 earlier versions
  1. Enrollment target: 40 to 30 Study description revisedv6 Show 1 more changeShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  2. Start date changed from estimate of Sep 1, 2024 to Sep 26, 2024 Study title expanded, about 1 wordv5 Show 1 more changeShow less
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Start date: Jul 1, 2024 to Sep 1, 2024 · Site details revised · Study title expanded, about 8 wordsv4 Show 3 more changesShow less
    • Start date: Jul 1, 2024 to Sep 1, 2024
    • Site details revised
    • Study title expanded, about 8 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study sites: 0 to 1v3
  5. Secondary endpoints revised (8)v2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure? * Does tailored text messaging improve self-care in adult patients with heart failure? Participants will be randomly assigned to one of two groups for 12 weeks: 1) intervention (text messaging); or 2) control group. Both groups will receive usual care, which includes regular follow-up visits at the heart failure clinic (standard care), plus a "Discharge Packet for Patients Diagnosed with Heart Failure", developed by the American Heart Association. Both groups will be asked via text messages and/or telephone calls to complete questionnaires at baseline/start, 4 weeks and 12 weeks, about self-care, quality of life, health beliefs, medications, diet, etc. Participants assigned to the intervention group will also receive approximately 5 text messages/week targeting medication adherence, heart-healthy diet, and self-monitoring for 12 weeks.
Trial Details
NCT Number NCT06473532
Lead Sponsor University of Illinois at Chicago
Conditions Heart Failure
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov